(Boursier.com) — MDxHealth , a specialist in commercial-stage precision diagnostics, has priced a registered public offering of 10,000,000 American Depositary Shares – each representing 10 common shares of the Company without par value – at an offer price of $4 per ADS for aggregate gross proceeds of $40 million before deducting commissions and estimated offering costs. As part of the offer, the group granted the underwriters a 30-day option to purchase 1,500,000 additional ADSs, under the same conditions and according to the same terms.
The offering is expected to close on February 7, 2023, subject to the satisfaction of customary closing conditions. The new shares underlying the offered ADSs will have the same rights and benefits as, and will be pari passu in all respects, including with respect to the right to dividends and distributions, with the existing ordinary shares of the Company and will be entitled to distributions for which the record date or maturity date falls on or after the issue date of the new shares. The group intends to use the net proceeds of the offering for general and working capital purposes, including to fund product development efforts and marketing activities.
©2023 Boursier.com